Figure 4 — The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

Research Paper|Volume 15, Issue 6|pp. 2136–2157

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

Back to articleFigure 4(4 of 6)

100%

Figure 4.The relations between CDKN2A expression and infiltration levels of different kinds of immune cell in cancer. Red is a positive correlation and blue is a negative correlation.